David A. Melnick

Insider Reports History

Entity
Individual
Location
C/O Spero Therapeutics, Inc., 675 Massachusetts Ave., 14 Th Floor, Cambridge, MA
Signature
/s/ Tamara Joseph, Attorney-in-Fact for David A. Melnick
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David A. Melnick:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. Chief Medical Officer Common Stock 62.1K $78.8K $1.27 Feb 1, 2022 Direct
Spero Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 53.2K $59.6K $1.12 Feb 1, 2022 Direct

Insider Reports Filed by David A. Melnick

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRO Spero Therapeutics, Inc. Feb 1, 2022 2 $0 4 Feb 3, 2022 Chief Medical Officer
SPRO Spero Therapeutics, Inc. Aug 26, 2021 1 $0 4 Aug 30, 2021 Chief Medical Officer